Evaxion stock jumps on expanded vaccine development pact with MSD
Evaxion Biotech ( EVAX) shares gained roughly 17% in early trade on Thursday after the company announced an expansion of its ...
FierceBiotech5 天
Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big back end
Merck & Co. has picked up options on two Evaxion vaccine candidates, paying $3.2 million and dangling more than $1 billion in ...
Evaxion Biotech Partners With Merck To Expand Vaccine Development
Evaxion Biotech enters an expanded collaboration with Merck, granting an option to license preclinical vaccine candidates.
Yahoo Finance5 天
Evaxion significantly expands vaccine development collaboration with MSD
Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3 Evaxion will host a conference call and webcast to discuss the agreement on ...
The Pharma Letter5 天
Evaxion significantly expands vaccine deal with MSD
Danish clinical-stage AI-based vaccine developer Evaxion Biotech (Nasdaq: EVAX) has entered into an option and license ...
Evaxion Biotech Gains Buy Rating Amid Merck Collaboration and AI-Driven Vaccine Development ...
Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on Evaxion Biotech (EVAX – Research Report). The ...
Seeking Alpha5 天
Evaxion stock jumps on expanded vaccine development pact with MSD
Evaxion Biotech (EVAX) shares gained roughly 17% in early trade on Thursday after the company announced an expansion of its vaccine development collaboration with MSD (NYSE:MRK) (tradename of ...
Evaxion Biotech (EVAX) Gets a Buy from Lake Street
In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on Evaxion Biotech (EVAX – Research Report), with a ...